the maintenance dose for the treatment of obesity is 2.4 mg subcutaneously once a week, whereas for diabetes, the maximum dose is 1 mg subcutaneously once a week
Liepinsh E, Makrecka-Kuka M, Volska K, Kuka J, Makarova E, Antone U, et al
Medvi offers care coaching, provider access, 24/7 support, and patient portal tools during treatment, but it doesnt clearly list a dedicated post-medication maintenance program
Efficacy and safety of Q10 ubiquinol with vitamins B and E in neurodevelopmental disorders: a retrospective chart review
Another important factor was it had the capacity to bind to albumin, a large protein common in the bloodstream, which would make the GLP-1 molecule too large to be quickly cleared by the kidney